Iaso Automated Medical Systems Limited

Acute Respiratory Distress Syndrome (ARDS) is hard to detect, and even harder to manage with fragmented health data consuming critical frontline healthcare time and energy. This can result in ARDS onset and a 45% mortality rate. What if there was a way to detect ARDS hours before the onset? Iaso Automated Medical Systems is a medical device company in New Zealand dedicated to helping intensivists achieve the best possible outcomes for critically-ill patients. Our team is on a mission to revolutionise detection and management of Acute Respiratory Distress Syndrome through powerful Machine Learning technology poised to help critical care teams make swift, evidence based decisions. We want to empower our frontline heroes with the right information, at the right time, for the right patients to benefit from proactive clinical care.